Literature DB >> 24981592

Role of age-related decrease of renal organic cation transporter 2 in the effect of atenolol on renal excretion of metformin in rats.

Jiangxia Ren1, Yan Zhou, Guoqiang Zhang, Liting Zhou, Jing Zhao, Yuhui Wei, Xin'an Wu.   

Abstract

Many diabetes patients, especially the elder ones, suffered from hypertension simultaneously. Therefore, it is very likely that a large number of diabetes patients receiving metformin hydrochloride may simultaneously be given beta-blockers. Knowing that both metformin and atenolol are eliminated by organic cation transporter 2 (OCT2/SLC22A2) expressed in the renal basolateral membrane, it is not clear whether there is a competitive effect on the renal excretion of metformin and/or atenolol when metformin and atenolol were co-administered, and whether age was involved in this drug-drug interaction. In this present study, both young rats (aged 3 months) and aged rats (aged 12 months) were used, rats were divided into metformin-treated group and metformin and atenolol co-administrated group, respectively. Either metformin (2.5 mg/kg) alone or metformin (2.5 mg/kg) in combination with atenolol (8 mg/kg) was administered to rats by tail vein injection. Then, urine was collected and the metformin concentration in urine was determined by HPLC. The localization and expression of rOCT2 in kidney were also investigated by Western blotting and immunohistochemistry. Significant differences of t 1/2, K e, CLtot and the accumulated metformin excretion in urine were founded in aged rats, but not in young rats, between metformin-treated group (2.002 ± 0.51 h, 0.346 ± 0.07/h, 57.161 ± 18.59 %, 4,287.087 ± 458.08 μg) and metformin plus atenolol-treated group (3.03 ± 0.67 h, 0.228 ± 0.05/h, 43.199 ± 10.28 %, 3,239.972 ± 446.61 μg). Moreover, a significant age-related decrease in rOCT2 protein expression was observed in the aged rats (P < 0.01), which may be responsible for the effect of atenolol on the renal excretion of metformin in the aged rats. In conclusion, there is a drug-drug interaction between atenolol and metformin, and more attention should be paid when atenolol and metformin were co-administered to the aged people inclinical.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24981592     DOI: 10.1007/s13318-014-0214-9

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  21 in total

1.  Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care.

Authors: 
Journal:  Diabet Med       Date:  2006-06       Impact factor: 4.359

2.  Multiple causes of death in old age.

Authors:  Yelena Gorina; Harold Lentzner
Journal:  Aging Trends       Date:  2008-02

3.  Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males.

Authors:  D F DAVIES; N W SHOCK
Journal:  J Clin Invest       Date:  1950-05       Impact factor: 14.808

4.  The effect of lansoprazole, an OCT inhibitor, on metformin pharmacokinetics in healthy subjects.

Authors:  Yi Ding; YanYan Jia; Ying Song; ChengTao Lu; YuWen Li; MinChun Chen; MingMing Wang; AiDong Wen
Journal:  Eur J Clin Pharmacol       Date:  2013-10-30       Impact factor: 2.953

Review 5.  Renal effects of beta blockade in essential hypertension.

Authors:  P W de Leeuw; W H Birkenhäger
Journal:  Eur Heart J       Date:  1983-07       Impact factor: 29.983

Review 6.  Beta-blockers and renal function.

Authors:  R Wilkinson
Journal:  Drugs       Date:  1982-03       Impact factor: 9.546

7.  Beta-blockers and the kidney: implications for renal function and renin release.

Authors:  M Epstein; J R Oster; N K Hollenberg
Journal:  Physiologist       Date:  1985-02

8.  Metformin transport by renal basolateral organic cation transporter hOCT2.

Authors:  Naoko Kimura; Masahiro Okuda; Ken-ichi Inui
Journal:  Pharm Res       Date:  2005-02       Impact factor: 4.200

9.  Functional involvement of the organic cation transporter 2 (rOct2) in the renal uptake of organic cations in rats.

Authors:  K-I Umehara; T Iwatsubo; K Noguchi; H Kamimura
Journal:  J Int Med Res       Date:  2008 Jan-Feb       Impact factor: 1.671

10.  Combined fibroblast growth factor receptor 4 cell membrane chromatography online with high performance liquid chromatography/mass spectrometry to screen active compounds in Brassica albla.

Authors:  Tao Zhang; Shengli Han; Jing Huang; Sicen Wang
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2012-11-01       Impact factor: 3.205

View more
  5 in total

Review 1.  Proximal Tubular Secretory Clearance: A Neglected Partner of Kidney Function.

Authors:  Ke Wang; Bryan Kestenbaum
Journal:  Clin J Am Soc Nephrol       Date:  2018-02-28       Impact factor: 8.237

2.  Physiologically Based Pharmacokinetic Modelling and Prediction of Metformin Pharmacokinetics in Renal/Hepatic-Impaired Young Adults and Elderly Populations.

Authors:  Su-Jin Rhee; Hyewon Chung; SoJeong Yi; Kyung-Sang Yu; Jae-Yong Chung
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-12       Impact factor: 2.441

Review 3.  Drug Transporters in the Kidney: Perspectives on Species Differences, Disease Status, and Molecular Docking.

Authors:  Wei Zou; Birui Shi; Ting Zeng; Yan Zhang; Baolin Huang; Bo Ouyang; Zheng Cai; Menghua Liu
Journal:  Front Pharmacol       Date:  2021-11-29       Impact factor: 5.810

4.  Aging increases the susceptibility of cisplatin-induced nephrotoxicity.

Authors:  Jiagen Wen; Meizi Zeng; Yan Shu; Dong Guo; Yi Sun; Zhen Guo; Youhong Wang; Zhaoqian Liu; Honghao Zhou; Wei Zhang
Journal:  Age (Dordr)       Date:  2015-11-03

Review 5.  Drug Interactions of Metformin Involving Drug Transporter Proteins.

Authors:  Naina Mohamed Pakkir Maideen; Abdurazak Jumale; Rajkapoor Balasubramaniam
Journal:  Adv Pharm Bull       Date:  2017-12-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.